Navigation Links
Alaven Pharmaceutical Introduces Kit for UC Patients
Date:6/9/2008

MARIETTA, Ga., June 9 /PRNewswire/ -- When patients with ulcerative colitis (UC) flare, their normal life can be completely disrupted. Bloody diarrhea, frantic urgency and abdominal pain make the bathroom the center of attention.

Alaven Pharmaceutical LLC, a specialty pharmaceutical company focused on developing and commercializing products to treat gastrointestinal conditions, today announced the introduction of a convenience Kit at the American Society of Colon and Rectal Surgeons' annual meeting in Boston. The Kit contains ROWASA(R) (mesalamine) Rectal Suspension Enema 4g/60mL, a treatment for flare symptoms associated with active mild to moderate left-sided UC, proctosigmoiditis, or ulcerative proctitis, and a personal cleansing wipe for added convenience for those inevitable restroom stops.*

"There is a continued need in the marketplace for convenient UC therapy for all patients living with the disease and facing the inevitability of flares," said Connie Swanson, VP, Sales and Marketing at Alaven. "Our hope is that by offering ROWASA in a convenience kit, patients will have access to a soothing topical treatment for more immediate flare relief and that they will be more comfortable with their medication-taking routine."

ROWASA is a prescription medication administered at bedtime for the relief of UC flare symptoms. Applied directly to the site of inflammation, ROWASA reduces rectal bleeding in as little as 3 days(1) and provides fast relief of diarrhea, abdominal pain, and other flare symptoms(2). The full course of treatment with ROWASA (3-6 weeks) is recommended for more complete flare relief(2).

Due to the unpredictable course of UC that is marked by periods of inactivity and then incidences of intermittent flares, patients are at an increased risk for poor adherence to medications. An estimated 34% of patients with left-sided UC have been shown to be non-compliant to prescribed medications(3). Research also shows that innovative ways, including providing convenient medications, may help to motivate patients to adhere(3).

The ROWASA convenience kit helps to improve the delivery and accessibility to reliable UC flare therapy while offering value-added convenience from a personal cleansing wipe that leaves UC patients clean and fresh.*

For additional information, visit http://www.ROWASA.com .

Important Safety Information

Contraindications: ROWASA is contraindicated for patients known to have hypersensitivity to the drug or any component of this medication.

Warning: ROWASA contains potassium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown but probably low.

Precautions: Mesalamine has been implicated in the production of an acute intolerance syndrome characterized by cramping, acute abdominal pain and bloody diarrhea, sometimes fever, headache and a rash; in such cases prompt withdrawal is required. Caution should be exercised when mesalamine is initially used in patients known to be allergic to sulfasalazine.

Adverse Reactions: ROWASA is usually well tolerated. Most adverse effects have been mild and transient. The most frequently reported adverse events include abdominal cramps, headache, gas, nausea, flu, fatigue, fever and rash.
For Full Prescribing Information - http://www.ROWASA.com .

*Wipe is optional and not a required part of treatment

1 Sutherland LR, et al. 5-aminosalicylic acid enema in the treatment of

distal ulcerative colitis, proctosigmoiditis, and proctitis.

Gastroenterology. 1987;92(6):1894-1898.

2 ROWASA Prescribing Information. Rev 05/08.

3 Kane SV, et al: The Challenge of Compliance and Persistence: Focus on

Ulcerative Colitis. J Manag Care Pharm. 2008;14(1)(suppl S-a):S2-S12.

Contact: Rose Raus

404-964-1834

rraus@dodgecommunications.com


'/>"/>
SOURCE Alaven Pharmaceutical LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2017)... ... May 19, 2017 , ... HealthSmart, the largest independent ... (Jim) Vertino as Chief Information Officer (CIO). He will be joining HealthSmart at ... and business performance. He defines strategic roadmaps by reimagining business processes—bridging the gap ...
(Date:5/21/2017)... ... 20, 2017 , ... Pot. Reefer. Grass. Mary Jane. No matter what people ... attributes like never before. More than a map, new social marketplace Weedable ... products – and for the first time – each other. A social marketplace like ...
(Date:5/21/2017)... ... May 21, 2017 , ... For more than 20 ... a wide range of knives and swords, from functional to fantasy. United Cutlery has ... with sleek, modern designs that defy tradition. , Offering a range of weapons and ...
(Date:5/19/2017)... (PRWEB) , ... May 19, 2017 , ... In a ... PlushBeds , a luxury online mattress company that specializes in natural and organic ... nation’s leading grassroots autism organization) for every unique share their recent viral Facebook ...
(Date:5/19/2017)... Mo (PRWEB) , ... May 19, 2017 , ... When ... May 20, his name will already appear on two major research studies that could ... been working with Dr. Matt Daggett, KCU alumnus and an orthopedic surgeon, alongside an ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... N.J. , May 17, 2017  Bayer announced ... oncology portfolio will be presented at the 53 rd ... Oncology (ASCO), taking place June 2-6 in ... presented at ASCO span prostate, colorectal, liver and thyroid ... analysis from the Phase II CHRONOS-1 trial of copanlisib ...
(Date:5/12/2017)... and Canada joint tech company Laughing Face has ... detergent, and features a powerful disinfection process. The company ... washes and sanitizes women,s panties or babies, cloth diapers in 25 ... ... an external water inlet. ...
(Date:5/10/2017)... , May 10, 2017 Global Health Intelligence ... Latin America , published its 2017 ranking of ... is based on extensive data analysis from GHI,s hospitals ... hospitals database for the region. The GHI database covers 86% ... offering more than 130 data points for each institution in ...
Breaking Medicine Technology: